The present application relates to the treatment of nematode infections. For example, the application relates to the use of compounds of Formula (I) and/or (II) as defined herein for treatment of a nematode infection or a disease, disorder or condition arising from a nematode infection:

##STR00001##

The present application relates to the treatment of nematode infections. For example, the application relates to the use of compounds of Formula (I) and/or (II) as defined herein for treatment of a nematode infection or a disease, disorder or condition arising from a nematode infection:

##STR00001##

A comprehensive nutrition pet food that satisfies a nutritional food standard for a dog or a cat, the comprehensive nutrition pet including a unicellular organism ingredient containing astaxanthin and being free of meals, in which a content of the astaxanthin is 0.0012% to 0.0080% by mass, relative to a total amount of the comprehensive nutrition pet food, and an a* value of the comprehensive nutrition pet food in an L*a*b* color space is 8.0 to 20.

A comprehensive nutrition pet food that satisfies a nutritional food standard for a dog or a cat, the comprehensive nutrition pet including a unicellular organism ingredient containing astaxanthin and being free of meals, in which a content of the astaxanthin is 0.0012% to 0.0080% by mass, relative to a total amount of the comprehensive nutrition pet food, and an a* value of the comprehensive nutrition pet food in an L*a*b* color space is 8.0 to 20.

A flavor composition comprising at least one compound that modulates, increases and/or enhances the activity of a calcium-sensing receptor that can be used to enhance the kokumi taste and/or palatability of pet food products is described herein. Also disclosed herein are methods for identifying said compounds.

A method of reducing methane production in a ruminant animal, comprising administering a methane reducer to a ruminant animal by proportionally dosing the methane reducer into a drinking water supply for the ruminant animal at a dosing rate selected to deliver the methane reducer to the ruminant animal in an effective manner.

A method of reducing methane production in a ruminant animal, comprising administering a methane reducer to a ruminant animal by proportionally dosing the methane reducer into a drinking water supply for the ruminant animal at a dosing rate selected to deliver the methane reducer to the ruminant animal in an effective manner.

Isoflavone-supplemented dry feed fed to young poultry animals provides total levels of isoflavones in the feed at about 1640 mg/kg feed to about 3890 mg/kg feed, and/or provides an additional about 750 mg/kg feed to about 3000 mg/kg feed. In response to ingesting the isoflavone-supplemented feed, the young poultry animal experiences improved performance.

The present disclosure relates generally to encapsulated strict obligate anaerobic bacteria, (e.g., Megasphaera eldesdenii and Ruminicoccus bromi), compositions comprising same, and the use of said capsules and/or compositions to deliver the strict obligate anaerobic bacteria to the gastrointestinal tract (GI) of an animal, such as a livestock animal (e.g., a ruminant or hindgut fermenter). The present disclosure relates to the encapsulation of strict obligate anaerobic bacteria which utilize lactic acid and/or starch and the use of those encapsulated bacteria in the field of animal health and nutrition. In particular examples, the present disclosure utilises porous capsules comprising surface pores with a molecular weight cut off between 50 and 200 kDa and wall comprising a complex formed from sodium cellulose sulphate and poly [dimethyldially-ammonium chloride].

The present disclosure relates generally to encapsulated strict obligate anaerobic bacteria, (e.g., Megasphaera eldesdenii and Ruminicoccus bromi), compositions comprising same, and the use of said capsules and/or compositions to deliver the strict obligate anaerobic bacteria to the gastrointestinal tract (GI) of an animal, such as a livestock animal (e.g., a ruminant or hindgut fermenter). The present disclosure relates to the encapsulation of strict obligate anaerobic bacteria which utilize lactic acid and/or starch and the use of those encapsulated bacteria in the field of animal health and nutrition. In particular examples, the present disclosure utilises porous capsules comprising surface pores with a molecular weight cut off between 50 and 200 kDa and wall comprising a complex formed from sodium cellulose sulphate and poly [dimethyldially-ammonium chloride].